United States Anti-Snoring Devices Market Insight
Published: 27 May 2026 | Report Format: Electronic (PDF)
The United States anti-snoring devices market is projected to register a CAGR of approximately 7.46% through 2035, driven by the rising prevalence of sleep apnea and sleep-related breathing disorders, increasing awareness regarding sleep health management, and growing consumer adoption of non-invasive respiratory support technologies.
U.S. Anti-Snoring Devices Market Insights Forecasts to 2035
- The US Anti-Snoring Devices Market Size Was Estimated at USD 1.18 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.46% from 2025 to 2035
- The US Anti-Snoring Devices Market Size is Expected to Reach USD 2.43 Billion by 2035
Notable Insights for U.S. Anti-Snoring Devices Market
- By product type, mandibular advancement devices accounted for nearly 36.9% share of the United States anti-snoring devices market in 2025.
- According to estimates published by the Centers for Disease Control and Prevention, nearly 39% of U.S. adults reported symptoms associated with sleep deprivation or sleep-related breathing disorders during 2025, while demand for home sleep monitoring and anti-snoring treatment devices increased by approximately 13.8% nationwide.
- Based on research initiatives linked to the National Institutes of Health, obstructive sleep apnea diagnosis rates across the United States increased by approximately 11.6% in 2025, accelerating the adoption of oral airway management devices, smart respiratory monitoring systems, and connected sleep therapy technologies.
Download the eBook (ToC)
- The United States represented approximately 41% of North America's sleep therapy and anti-snoring devices market revenue in 2025, reinforcing the country is strategic leadership within the global sleep healthcare and respiratory wellness ecosystem.
What Makes Decisions Advisors Research Unique?
- Sleep Healthcare Intelligence and Respiratory Device Forecasting
Decisions Advisors delivers specialized healthcare market intelligence through comprehensive evaluation of sleep disorder prevalence trends, respiratory therapy innovations, home healthcare adoption, wearable sleep technologies, and consumer wellness device demand.
- Advanced Sleep Therapy Research Methodology and Clinical Validation
Our analytical methodology integrates sleep clinic assessments, physician interviews, respiratory care evaluations, FDA regulatory analysis, healthcare reimbursement trends, and secondary clinical benchmarking to generate highly accurate market forecasts and actionable business intelligence.
- Sleep Technology Benchmarking and Competitive Landscape Analysis
The study provides a comprehensive analysis of mandibular advancement devices, smart nasal dilators, positional therapy systems, wearable sleep tracking technologies, oral airway stabilization products, and connected respiratory wellness platforms.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Anti-Snoring Devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Anti-Snoring Devices Market
- ResMed Inc.
- Koninklijke Philips N.V.
- SomnoMed Limited
- Apnea Sciences Corporation
- Airway Management Inc.
- GlaxoSmithKline plc
- TheraSnore
- ZQuiet LLC
- Illusion Aligners
- Others
Recent Developments:
- In April 2026, ResMed Inc. invested approximately USD 240 Million toward the expansion of digital sleep health technologies and connected respiratory therapy platforms across North America, supporting enhanced remote monitoring and home-based sleep apnea management capabilities.
- In September 2025, Koninklijke Philips N.V. introduced an advanced wearable sleep monitoring and anti-snoring therapy platform integrating AI-enabled respiratory analytics, improving sleep disorder detection efficiency by approximately 19% across selected clinical pilot programs.
Market Segmentation:
United States Anti-Snoring Devices Market, By Product Type
- Mandibular Advancement Devices
- Tongue Stabilizing Devices
- Nasal Dilators
- Positional Control Devices
- Chin Straps
- EPAP Devices
- Others
United States Anti-Snoring Devices Market, By Distribution Channel
- Hospitals
- Sleep Clinics
- Retail Pharmacies
- Online Channels
United States Anti-Snoring Devices Market, By End User
- Adults
- Geriatric Population
- Obese Patients
- Sleep Apnea Patients
Expert Views:
According to healthcare industry analysts, the U.S. anti-snoring devices market is expected to witness sustainable long-term growth due to rising sleep disorder prevalence, increasing consumer awareness regarding sleep health, and expanding adoption of non-invasive respiratory therapy technologies. Experts indicate that AI-enabled sleep monitoring systems, connected home healthcare devices, and advanced mandibular advancement technologies will remain major strategic priorities for medical device manufacturers and respiratory healthcare providers.
Author: Govind and Krishna By Spherical Insights and Consulting